Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
25.00
+0.84 (3.48%)
At close: Aug 22, 2025, 4:00 PM
25.00
0.00 (0.00%)
After-hours: Aug 22, 2025, 4:30 PM EDT

Inhibrx Biosciences Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Inhibrx Biosciences.

Price Target: $ (0.00%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Pricen/an/an/an/a
Changen/an/an/an/a

Analyst Ratings

The average analyst rating for Inhibrx Biosciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy000000
Buy000000
Hold111112
Sell000000
Strong Sell000000
Total111112

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
JMP Securities
JMP Securities
Hold
Reiterates
n/a
HoldReiteratesn/an/aAug 22, 2025
JMP Securities
JMP Securities
Hold
Reiterates
n/a
HoldReiteratesn/an/aMay 15, 2025
Citizens Capital Markets
Citizens Capital Markets
Hold
Reiterates
n/a
HoldReiteratesn/an/aMar 18, 2025
JMP Securities
JMP Securities
Hold
Reiterates
n/a
HoldReiteratesn/an/aJan 22, 2025
JMP Securities
JMP Securities
Hold
Initiates
n/a
HoldInitiatesn/an/aJul 23, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 200.00K
Revenue Next Year
4.39M
EPS This Year
-10.95
from 112.62
EPS Next Year
-10.18
from -10.95
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.32M1.80M200.00K-4.39M
Revenue Growth
-36.88%-88.89%--
EPS
--20.48112.62-10.95-10.18
EPS Growth
-----
Forward PE
-----
No. Analysts
---33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026
Highn/a4.5M
Avgn/a4.4M
Lown/a4.2M

Revenue Growth

Revenue Growth20252026
High--
Avg--
Low--

EPS Forecast

EPS20252026
High-11.28-10.48
Avg-10.95-10.18
Low-10.52-9.78

EPS Growth

EPS Growth20252026
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.